Prevalence and some important risk factors of hypertension in Ban Paew District, second report

Journal of the Medical Association of Thailand

Volumn 94, Issue 9, 2011, Pages 1069-1076

  Puavilai, Wilai ^a   Laorugpongse, Donphichit ^b   Prompongsa, Saowaluck ^a   Sutheerapatranont, Sutham ^a   Siriwiwattnakul, Napa ^a   Muthapongthavorn, Namtip ^a   Srilert, Pratueng ^a   Jakpechyothin, Jongrak ^a  

^a RAJAVITHI HOSPITAL   (Thailand)

^b Bangkok Heart Hospital   (Thailand)

Author keywords

Ban Paew District; Hypertension; Prevalence of hypertension; Risk factors of hypertension

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANALYTICAL PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; THAILAND; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL DRINKING; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SOCIOECONOMIC FACTORS; THAILAND;

EID: 80053080452     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356: 1955-1964.
3. The Thai Acute Coronary Syndrome Registry (TACSR). Bangkok: The Heart Association of Thailand under the Royal Patronage of H.M. the King; 2006.
4. th ed. New York: McGraw Hill; 2008: 1551-1569.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
6. Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens 2000; 14: 749-763.
7. Kachacheewa U, Intharakoses A, Sindhavananda K. Epidemiological studies of cardiovascular disease in a Community-Chaiyo, Ang-Thong, Thailand. Bull Dept Med Serv 1978; 3: 37-81.
8. Sitthi-Amorn C, Chandraprasert S, Bunnag SC, Plengvidhya CS. The prevalence and risk factors of hypertension in Klong Toey slum and Klong Toey government apartment houses. Int J Epidemiol 1989; 18: 89-94.
9. The Sixth Report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure. NIH Publication. No. 98-4080. Bethesda, MD: National Institutes of Health National Heart, Lung, and Blood Institute National High Blood Pressure Education Program; 1997.
10. Puavilai W, Laorugpongse D. Hypertension at Ampur Ban Paew and Some Risk Factors of Hypertension. Bull Dept Med Serv 2000; 25: 116-123.
11. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544.
12. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hyper- tension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-536.
13. Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation 2005; 112: 1651-1662.
14. Chittinandana A, Chailimpamontree W, Chaloeiphap P. Prevalence of chronic kidney disease in Thai adult population. J Med Assoc Thai 2006; 89 (Suppl 2): S112-S120.
15. The Survey Report of Behavioral Risk Factors of Non-Communicable Disease and Injuries in Thailand. The Bureau of Non-Communicable Disease; Department of Disease Control, Ministry of Public Health, Thailand; 2005.
16. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287: 1003-1010.
17. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
18. Gupta PC, Gupta R, Pednekar MS. Hypertension prevalence and blood pressure trends in 88,653 subjects in Mumbai, India. J Hum Hypertens 2004; 18: 907-910.
19. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
20. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, et al. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006; 84: 461-469.
21. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369.
22. Oh JY, Hong YS, Sung YA, Barrett-Connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004; 27: 2027-2032.
23. Victor RG, Kaplan NM. Systemic hypertension: mechanisms and diagnosis. In: Libby P, Bonow RO, Mann DL, Zipes DP, editors. Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia: Elsevier Saunders; 2008: 1027-1048.
24. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38: 827-832.
25. Ueshima H, Shimamoto T, Iida M, Konishi M, Tanigaki M, Doi M, et al. Alcohol intake and hypertension among urban and rural Japanese populations. J Chronic Dis 1984; 37: 585-592.
26. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
27. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319-328.
28. Bener A, Al Suwaidi J, Al Jaber K, Al Marri S, Elbagi IE. Epidemiology of hypertension and its associated risk factors in the Qatari population. J Hum Hypertens 2004; 18: 529-530.
29. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.